Why Bristol-Myers Squibb (BMY) Stock Is Trading Lower Today
Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) fell 4.2% in the afternoon session after the company lowered…
BioNTech Stock Jumps on Bristol Myers Squibb Cancer Drug Collaboration
Sean Gallup / Getty Images Bristol Myers Squibb will pay $1.5 billion to BioNTech up front, with up…
BioNTech Gains 20% On $11.1 Billion Bristol Deal
BioNTech (NASDAQ:BNTX) surged 20% after Bristol Myers Squibb (NYSE:BMY) agreed to license its bispecific antibody BNT327targeting PD-L1 and…